A Complication of Phototherapy in the Newborn: The "Bronze Baby"

Sharma, Raj K.; Ente, Gerald; Collipp, Platon J.; Maddaiah, Vaddanahally T.; Rezvani, Iraj
April 1973
Clinical Pediatrics;Apr1973, Vol. 12 Issue 4, p231
Academic Journal
A newborn infant bad an unusual reversible complication caused by light therapy for hyperbilirubinemia. A dark grey-brown color of the skin, urine, and serum developed on the fifth day, after 24 hours of light therapy. Serum bilirubin (direct and total), SGOT, and LDH were elevated. The infant recovered, and bilirubin and enzymes returned to normal after a period of three weeks. A possible pathologic mechanism for this complication is suggested.


Related Articles

  • How to use: transcutaneous bilirubinometry. O'Connor, Matthew C.; Lease, Meredith A.; Whalen, Bonny L. // Archives of Disease in Childhood -- Education & Practice Edition;Aug2013, Vol. 98 Issue 4, p154 

    The National Institute for Health and Clinical Excellence neonatal jaundice guidelines recommend checking the bilirubin level in all infants with visible jaundice. The gold standard for this measurement is total serum bilirubin (TSB). Transcutaneous bilirubinometry (TcB) is an alternative to TSB...

  • Phototherapy for neonatal jaundice in infants with cephalhematomas. Tan, K.L.; Lim, G.C. // Clinical Pediatrics;Jan1995, Vol. 34 Issue 1, p7 

    Evaluates the effect of cephalhematomas on the efficacy of phototherapy for neonatal jaundice. Measurement of irradiance on infant skin; Sampling of capillary blood at 12-hourly intervals; Description of subjects; Lack of additional intravascular hemolysis among infants with cephalhematoma.

  • Late effects of phototherapy.  // Pediatrics for Parents;1997, Vol. 17 Issue 11, p7 

    Focuses on a study on the long-term harmful effects of phototherapy, which is used to treat jaundice in newborn infants by exposing them to fluorescent light, as found in `Family Practice News,' Volume 3, Number 1, 1998. Question over the increase of the chances of cancer development with this...

  • Tips from Other Journals. CRAWFORD-FAUCHER, AMY // American Family Physician;8/15/2010, Vol. 82 Issue 4, p426 

    The article summarizes the findings of several studies on hyperbilirubinemia screening to prevent chronic bilirubin encephalopathy among newborn infants published in the journal "Pediatrics." One found lack of high-quality evidence to determine the value of hyperbilirubinemia screening. Another...

  • Ohmeda Biliblanket vs Wallaby phototherapy system for the reduction of bilirubin levels in the... George, Phillip; Lynch, Marilyn // Clinical Pediatrics;Mar1994, Vol. 33 Issue 3, p178 

    Compares the Ohmeda Biliblanket Phototherapy System and the Wallaby Phototherapy System in reducing bilirubin concentrations in term neonates with physiologic jaundice in the home-care setting. Mechanisms of operation of phototherapy systems; Study protocol; Efficiencies in reduction of...

  • Phototherapy in children requires careful assessment. Guttman, Cheryl // Dermatology Times;Sep99, Vol. 20 Issue 9, p15 

    Focuses on the need to assess the effectiveness of phototherapy as a treatment for pediatric patients with recalcitrant dermatoses. Risk factors for the use of phototherapy; Contraindications for using the treatment option in children.

  • Jaundice in a newborn. Maisels, M. Jeffrey // Contemporary Pediatrics;May2005, Vol. 22 Issue 5, p41 

    Presents methods for determining a newborn's likelihood of developing severe jaundice. Guidelines for preventing and managing hyperbilirubinemia; Factors that affected the risk of severe hyperbilirubinemia; Clinical plan for managing the newborn readmitted for phototherapy or exchange...

  • AAP guidelines for phototherapy in hospitalized infants born at ≥ 35 weeks' gestation.  // Contemporary Pediatrics;May2005, Vol. 22 Issue 5, p50 

    Provides information on the American Academy of Pediatrics guidelines for the use of phototheraphy in hospitalized infants. Risk factors associated with phototherapy; Presence of hemolysis in a total serum bilirubin level that does not decrease or continues to rise in an infant who is receiving...

  • Management of hyperbilirubinemia and prevention of kernicterus in 20 patients with Crigler-Najjar disease. Strauss, Kevin A.; Robinson, Donna L.; Vreman, Hendrik J.; Puffenberger, Erik G.; Hart, Graham; Morton, D. Holmes // European Journal of Pediatrics;May2006, Vol. 165 Issue 5, p306 

    We summarize the treatment of 20 patients with Crigler-Najjar disease (CND) managed at one center from 1989 to 2005 (200 patient-years). Diagnosis was confirmed by sequencing the UGTA1A gene. Nineteen patients had a severe (type 1) phenotype. Major treatment goals were to maintain the bilirubin...


Read the Article


Sign out of this library

Other Topics